eMedicine Specialties > Emergency Medicine > Endocrine & Metabolic

Adrenal Insufficiency and Adrenal Crisis: Treatment & Medication

Author: Kevin M Klauer, DO, FACEP, Assistant Clinical Professor, Michigan State University College of Osteopathic Medicine; Director, Quality and Clinical Education, Emergency Medicine Physicians, Ltd; Director, Center for Emergency Medical Education; Editor-in-Chief, Emergency Physicians Monthly
Contributor Information and Disclosures

Updated: Dec 16, 2009

Treatment

Emergency Department Care

  • Maintain airway, breathing, and circulation in patients with adrenal crisis.
  • Use coma protocol (ie, glucose, thiamine, naloxone).
  • Use aggressive volume replacement therapy (dextrose 5% in normal saline solution [D5NS]).
  • Correct electrolyte abnormalities as follows:
  • Use dextrose 50% as needed for hypoglycemia.
  • Administer hydrocortisone 100 mg intravenously (IV) every 6 hours. During adrenocorticotropic hormone (ACTH) stimulation testing, dexamethasone (4 mg IV) can be used instead of hydrocortisone to avoid interference with testing of cortisol levels.
  • Administer fludrocortisone acetate (mineralocorticoid) 0.1 mg every day.
  • Always treat the underlying problem that precipitated the crisis.

Consultations

  • Endocrine consultation following admission is beneficial. If no endocrinologist is available, a general internist can manage the process. Emergency management should be implemented in the ED prior to consultation when sufficient clinical suspicion for this diagnosis is present.
  • ICU admission is necessary for most patients with acute adrenal insufficiency and adrenal crisis.

Medication

One of the goals in treating adrenal insufficiency is glucocorticoid replacement.5 Electrolyte and metabolic abnormalities, as well as hypovolemia, must also be corrected. In addition, address the event precipitating abrupt decompensation.

Corticosteroids

These agents are primarily used to correct glucocorticoid deficiencies. The drugs of choice are hydrocortisone, cortisone, and prednisone.


Hydrocortisone (Cortef, Solu-Cortef)

DOC because of mineralocorticoid activity and glucocorticoid effects.

Adult

100 mg IV bolus; follow by 100 mg q8h continuous infusion for 24-48 h
Once patient is stable, PO hydrocortisone may be started at 50 mg q8h for another 48 h; may taper dose until dosage is 30-50 mg/d in divided doses
Taper dose over 14 d; discontinue once symptoms resolve

Pediatric

<12 years: 1-2 mg/kg IV bolus; follow by 25-150 mg/d divided q6-8h
>12 years: 1-2 mg/kg IV bolus; follow by 150-250 mg/d divided q6-8h

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May lower serum potassium levels; complications of hypokalemia (eg, digitalis toxicity) may ensue; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections are possible complications of glucocorticoid use


Cortisone acetate (Cortone Acetate)

Considered the DOC by some practitioners.

Adult

25-300 mg/d PO/IM divided q12-24h

Pediatric

25-300 mg/d PO/IM divided q12-24h; 0.25-0.35 mg/kg/d IM qd or 12.5 mg/m2/d

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May lower serum potassium levels; complications of hypokalemia (eg, digitalis toxicity) may ensue; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections are possible complications of glucocorticoid use


Prednisone (Deltasone, Liquid Pred)

Treats various diseases including adrenocortical insufficiency. Agent is inactive and must be metabolized to active metabolite prednisolone. Conversion may be impaired in patients with liver disease.

Adult

5-60 mg/d PO qd or divided bid/qid

Pediatric

4-5 mg/m2/d PO; alternatively, administer 1-2 mg/kg PO qd; taper over 2 wk as symptoms resolve

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May lower serum potassium levels; complications of hypokalemia (eg, digitalis toxicity) may ensue; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections are possible complications of glucocorticoid use


Dexamethasone (Decadron, AK-Dex, Alba-Dex, Dexone)

Alternative to hydrocortisone to avoid interference with testing of cortisol levels.

Adult

4 mg IV; repeat q2-6h if necessary

Pediatric

0.03-0.15 mg/kg/d IV divided q6-12h

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May lower serum potassium levels; complications of hypokalemia (eg, digitalis toxicity) may ensue; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections are possible complications of glucocorticoid use


Fludrocortisone acetate (Florinef Acetate)

Partial replacement therapy for primary and secondary adrenocortical insufficiency.

Adult

0.1 mg PO qd

Pediatric

0.05-0.1 mg PO qd

Antagonizes effects of anticholinergics; rifampin, hydantoins, and barbiturates decrease effects of fludrocortisone; decreases salicylate levels

Documented hypersensitivity; systemic fungal infections

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Taper dose gradually when therapy is discontinued; caution in Addison disease, potassium loss, and sodium retention

More on Adrenal Insufficiency and Adrenal Crisis

Overview: Adrenal Insufficiency and Adrenal Crisis
Differential Diagnoses & Workup: Adrenal Insufficiency and Adrenal Crisis
Treatment & Medication: Adrenal Insufficiency and Adrenal Crisis
Follow-up: Adrenal Insufficiency and Adrenal Crisis
Multimedia: Adrenal Insufficiency and Adrenal Crisis
References
[ CLOSE WINDOW ]

References

  1. Wyngaarden JB, Smith LH, Bennett JC. Adrenocortical hypofunction. Cecil Textbook of Medicine. 19th ed. WB Saunders; 1992:1271-1288.

  2. Hahner S, Loeffler M, Bleicken B, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency - the need for new prevention strategies. Eur J Endocrinol. Dec 2 2009;[Medline].

  3. Lundy JB, Slane ML, Frizzi JD. Acute adrenal insufficiency after a single dose of etomidate. J Intensive Care Med. Mar-Apr 2007;22(2):111-7. [Medline].

  4. [Guideline] Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. Jun 2008;36(6):1937-49. [Medline].

  5. Hahner S, Allolio B. Therapeutic management of adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. Apr 2009;23(2):167-79. [Medline].

  6. Aono J, Mamiya K, Ueda W. Abrupt onset of adrenal crisis during routine preoperative examination in a patient with unknown Addison's disease. Anesthesiology. Jan 1999;90(1):313-4. [Medline].

  7. Braunwald E, Isselbacher KJ, Fauci AS, et al. Hypofunction of adrenal cortex. In: Harrison's Principles of Internal Medicine. 11th ed. McGraw-Hill; 1987:1764-1771.

  8. Carson PP. Emergency. Adrenal crisis. Am J Nurs. Jul 2000;100(7):49-50. [Medline].

  9. Chin R. Adrenal crisis. Crit Care Clin. Jan 1991;7(1):23-42. [Medline].

  10. Cronin CC, Callaghan N, Kearney PJ, et al. Addison disease in patients treated with glucocorticoid therapy. Arch Intern Med. Feb 24 1997;157(4):456-8. [Medline].

  11. Dluhy RG. Assessment of systemic corticosteroid activity. Respir Med. Nov 1997;91 Suppl A:32-3. [Medline].

  12. Duclos M, Guinot M, Colsy M, Merle F, Baudot C, Corcuff JB, et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc. Jul 2007;39(7):1036-43. [Medline].

  13. Gilliland PF. Endocrine emergencies. Adrenal crisis, myxedema coma, and thyroid storm. Postgrad Med. Nov 1983;74(5):215-20, 225-7. [Medline].

  14. Guyton AC, et al. The adrenocortical hormones. In: Textbook of Medical Physiology. 7th ed. WB Saunders; 1986:909-919.

  15. Lelubre C, Lheureux PE. Epigastric pain as presentation of an addisonian crisis in a patient with Schmidt syndrome. Am J Emerg Med. Feb 2008;26(2):251.e3-4. [Medline].

  16. Omori K, Nomura K, Shimizu S. Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocr J. Dec 2003;50(6):745-52. [Medline].

  17. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am. Mar 2000;29(1):43-56. [Medline].

  18. Rosen P. Endocrine disorders. In: Emergency Medicine: Concepts and Clinical Practice. 3rd ed. Mosby-Year Book; 1992:2252-2259.

  19. Rusnak RA. Adrenal and pituitary emergencies. Emerg Med Clin North Am. Nov 1989;7(4):903-25. [Medline].

  20. Simm PJ, McDonnell CM, Zacharin MR. Primary adrenal insufficiency in childhood and adolescence: advances in diagnosis and management. J Paediatr Child Health. Nov 2004;40(11):596-9. [Medline].

  21. Tuchelt H, Dekker K, Bahr V, Oelkers W. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease. Clin Endocrinol (Oxf). Sep 2000;53(3):301-7. [Medline].

  22. Vesely DL. Hypoglycemic coma: don't overlook acute adrenal crisis. Geriatrics. May 1982;37(5):71-3, 76-7. [Medline].

  23. Wiltshire EJ, Wilson R, Pringle KC. Addison's disease presenting with an acute abdomen and complicated by cardiomyopathy. J Paediatr Child Health. Nov 2004;40(11):644-5. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

adrenal insufficiency, adrenal crisis, adrenocortical insufficiency, severe acute adrenocortical insufficiency, primary adrenocortical insufficiency, primary adrenal insufficiency, secondary adrenocortical insufficiency, secondary adrenal insufficiency, treatment, diagnosis, symptoms

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Kevin M Klauer, DO, FACEP, Assistant Clinical Professor, Michigan State University College of Osteopathic Medicine; Director, Quality and Clinical Education, Emergency Medicine Physicians, Ltd; Director, Center for Emergency Medical Education; Editor-in-Chief, Emergency Physicians Monthly
Kevin M Klauer, DO, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Medical Editor

Erik D Schraga, MD, Consulting Staff, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates; Consulting Staff, Permanente Medical Group, Kaiser Permanente, Santa Clara Medical Center
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Howard A Bessen, MD, Professor of Medicine, Department of Emergency Medicine, UCLA School of Medicine; Program Director, Harbor-UCLA Medical Center
Howard A Bessen, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Erik D Schraga, MD, Consulting Staff, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates; Consulting Staff, Permanente Medical Group, Kaiser Permanente, Santa Clara Medical Center
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.